首页12尾页 共 40 条记录, 当前第1/2页。
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
2014/1/11 12:00
Conditions:   Recurrent Breast Cancer;   Metastatic Breast Cancer
Interventions:   Drug: Ruxolitinib;   Drug: Paclitaxel
Sponsors:   Dana-Farber Cancer Institute;   Incyte Corporation
Not yet recruiting - verified January 2014
Famotidine in Schizophrenia
2013/8/23 12:00
Condition:   Schizophrenia
Interventions:   Drug: Famotidine;   Drug: Placebo
Sponsors:   Helsinki University;   Jesper Ekelund;   Karolinska Institutet;   Stockholm County Council, Sweden;   Social services and Healthcare, City of Helsinki, Finland;   Stanley Medical Research Institute;   Ahokas foundation, Finland
Not yet recruiting - verified September 2013
Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes
2013/8/20 12:00
Condition:   Heartburn
Interventions:   Drug: Talcid (Hydrotalcite, BAY4516H);   Drug: Famotidine;   Drug: Placebo
Sponsors:   Bayer;   Bayer
Completed - verified August 2013
A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
2013/4/24 12:00
Condition:   Chronic Lymphocytic Leukemia
Interventions:   Drug: Treatment A;   Drug: Treatment B;   Drug: Treatment C;   Drug: Treatment D;   Drug: Treatment E;   Drug: Treatment F;   Drug: Treatment G;   Drug: Treatment H;   Drug: Treatment I;   Drug: Treatment J
Sponsors:   Gilead Sciences;   Gilead Sciences
Not yet recruiting - verified April 2013
Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits
2012/11/17 12:00
Condition:   Healthy
Intervention:   Drug: Taste Test
Sponsors:   Mayo Clinic;   Mayo Clinic
Recruiting - verified November 2012
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
2012/3/20 12:00
Condition:   Juvenile Idiopathic Arthritis
Intervention:   Drug: 800 mg ibuprofen/26.6 mg famotidine
Sponsors:   Horizon Pharma, Inc.;   Pediatric Rheumatology Collaborative Study Group
Not yet recruiting - verified March 2012
Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions
2012/1/12 12:00
Condition:   Healthy
Interventions:   Drug: Famotidine;   Drug: Pepcid
Sponsor:   Dr. Reddy's Laboratories Limited
Completed - verified January 2012
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
2011/12/21 12:00
Condition:   Erosive Esophagitis
Interventions:   Drug: Lafutidine;   Drug: Famotidine;   Drug: Omeprazole
Sponsor:   Boryung Pharmaceutical Co., Ltd
Enrolling by invitation - verified December 2011
Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
2011/8/2 12:00
Conditions:   Peptic Ulcer Bleeding;   Gastritis H Pylori;   Atherothrombotic Diseases
Interventions:   Drug: Rabeprazole;   Drug: Famotidine
Sponsor:   Chinese University of Hong Kong
Recruiting - verified August 2011
Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade
2011/4/8 12:00
Condition:   Readiness to Discharge
Interventions:   Procedure: Peri-Articular Injection;   Procedure: Epidural Pathway (PCEA+FNB)
Sponsor:   Hospital for Special Surgery, New York
Recruiting - verified April 2011
Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
2011/2/2 12:00
Condition:   Acute Myelogenous Leukemia
Intervention:   Drug: Interleukin-2
Sponsor:   Leo W. Jenkins Cancer Center
Recruiting - verified February 2011
Drug-Drug Interaction (DDI) H2 Antagonists
2010/10/29 12:00
Condition:   HIV
Interventions:   Drug: Atazanavir;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir;   Drug: Tenofovir;   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Famotidine;   Drug: Famotidine
Sponsor:   Bristol-Myers Squibb
Recruiting - verified October 2010
Proton-Pump Inhibitor Versus Histamine-2 Receptor Antagonist in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
2010/8/3 12:00
Condition:   Peptic Ulcer
Interventions:   Drug: Lansoprazole;   Drug: Famotidine
Sponsor:   Chinese University of Hong Kong
Recruiting - verified January 2011
A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition
2010/2/18 12:00
Condition:   Healthy
Intervention:   Drug: Famotidine
Sponsor:   Ranbaxy Laboratories Limited
Completed - verified March 2010
A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition
2010/2/18 12:00
Condition:   Healthy
Intervention:   Drug: Famotidine
Sponsor:   Ranbaxy Laboratories Limited
Completed - verified March 2010
Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin
2010/2/2 12:00
Conditions:   Acute Coronary Syndrome;   Acute Myocardial Infarction
Interventions:   Drug: esomeprazole 20 mg daily;   Drug: famotidine 40 mg daily
Sponsor:   Ruttonjee Hospital
Completed - verified October 2010
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients
2009/10/22 12:00
Conditions:   HIV-1 Infection;   HIV Infections
Interventions:   Drug: MK0518 (Raltegravir);   Drug: famotidine;   Drug: omeprazole
Sponsor:   Merck
Completed - verified May 2010
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug (NSAID) Treatment
2009/9/23 12:00
Conditions:   Osteoarthritis;   Rheumatoid Arthritis;   Chronic Low Back Pain;   Chronic Regional Pain Syndrome;   Chronic Soft Tissue Pain
Intervention:   Drug: HZT-501
Sponsor:   Horizon Therapeutics, Inc.
Active, not recruiting - verified July 2010
Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
2009/9/15 12:00
Conditions:   Aspirin;   Dyspepsia
Interventions:   Drug: esomeprazole;   Drug: Famotidine
Sponsors:   Ruttonjee Hospital;   Queen Mary Hospital, Hong Kong
Recruiting - verified July 2010
A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets
2009/7/22 12:00
Condition:   Heartburn
Interventions:   Drug: famotidine (+) calcium carbonate (+) magnesium hydroxide tablet;   Drug: Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water;   Drug: Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water
Sponsor:   Merck
Completed - verified July 2009